2018
DOI: 10.1002/eat.22939
|View full text |Cite
|
Sign up to set email alerts
|

A causality dilemma: ARFID, malnutrition, psychosis, and hypomagnesemia

Abstract: We present a novel case of a woman with coincident occurrence of auditory and visual hallucinations, electrolyte disturbances, chloride unresponsive alkalosis, and an eating disorder. The patient was ultimately diagnosed with Gitelman syndrome comorbid with schizophreniform disorder and avoidant restrictive food intake disorder. Eating disorders are often associated with electrolyte abnormalities which, in turn, can cause or contribute to other neuropsychiatric symptoms. At the same time, psychotic disorders c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 14 publications
0
5
0
Order By: Relevance
“…Whilst similar levels of dietary restriction were observed in the cohorts studied, patients with ARFID were found to display clinically-distinct presentations compared to those with other EDs, including a history of abdominal pain, a longer length of illness and a distinct absence of any cognitions relating to weight or body image (Nakai et al, 2017;Becker et al, 2018;Izquierdo et al, 2018;Lieberman et al, 2019). Several case studies (n = 6) also reported that ARFID can develop in the context of various secondary medical or psychiatric illnesses, including food avoidance associated with drug use (Lazare, 2017), dietary restriction due to gastrointestinal discomfort following surgery (Tsai et al, 2017) and two cases of ARFID occurring alongside psychosis (Wassenaar et al, 2018;Westfall et al, 2018).…”
Section: Clinical Characteristicsmentioning
confidence: 99%
“…Whilst similar levels of dietary restriction were observed in the cohorts studied, patients with ARFID were found to display clinically-distinct presentations compared to those with other EDs, including a history of abdominal pain, a longer length of illness and a distinct absence of any cognitions relating to weight or body image (Nakai et al, 2017;Becker et al, 2018;Izquierdo et al, 2018;Lieberman et al, 2019). Several case studies (n = 6) also reported that ARFID can develop in the context of various secondary medical or psychiatric illnesses, including food avoidance associated with drug use (Lazare, 2017), dietary restriction due to gastrointestinal discomfort following surgery (Tsai et al, 2017) and two cases of ARFID occurring alongside psychosis (Wassenaar et al, 2018;Westfall et al, 2018).…”
Section: Clinical Characteristicsmentioning
confidence: 99%
“…To our knowledge, the only prior mention of this comorbidity was a case report of a patient with ARFID and Gitelman syndrome. 36 Anxiety and depression…”
Section: Discussionmentioning
confidence: 99%
“…The remaining 267 articles were examined according to the eligibility criteria mentioned above for possible selection; 220 articles were eliminated. Finally, 47 articles were chosen for analysis, nevertheless, six articles were excluded because three of them provided a diagnosis other than ARFID (Lazare, et al, 2017;Toufexis, et al 2015;Wassenaar et al, 2018) and the remaining three articles were used to exemplify characteristics or research ideas and/or did not apply clinical intervention (Kreipe & Palomaki, 2012;Lucarelli, et al, 2017;Menzel, et al, 2018). Figure 1 presents the flowchart of the screening process.…”
Section: Study Selectionmentioning
confidence: 99%